Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.02.023

Related search